Lyman W. Whitlatch, Ph.D. - Publications

Affiliations: 
2003 Boston University, Boston, MA, United States 
Area:
Cell Biology, Molecular Biology, Oncology

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2006 Flanagan JN, Young MV, Persons KS, Wang L, Mathieu JS, Whitlatch LW, Holick MF, Chen TC. Vitamin D metabolism in human prostate cells: implications for prostate cancer chemoprevention by vitamin D. Anticancer Research. 26: 2567-72. PMID 16886665  0.733
2004 Wang L, Flanagan JN, Whitlatch LW, Jamieson DP, Holick MF, Chen TC. Regulation of 25-hydroxyvitamin D-1alpha-hydroxylase by epidermal growth factor in prostate cells. The Journal of Steroid Biochemistry and Molecular Biology. 89: 127-30. PMID 15225759 DOI: 10.1016/J.Jsbmb.2004.03.091  0.749
2004 Young MV, Schwartz GG, Wang L, Jamieson DP, Whitlatch LW, Flanagan JN, Lokeshwar BL, Holick MF, Chen TC. The prostate 25-hydroxyvitamin D-1 alpha-hydroxylase is not influenced by parathyroid hormone and calcium: implications for prostate cancer chemoprevention by vitamin D. Carcinogenesis. 25: 967-71. PMID 14729578 DOI: 10.1093/Carcin/Bgh082  0.765
2003 Wang L, Whitlatch LW, Flanagan JN, Holick MF, Chen TC. Vitamin D autocrine system and prostate cancer. Recent Results in Cancer Research. Fortschritte Der Krebsforschung. ProgrèS Dans Les Recherches Sur Le Cancer. 164: 223-37. PMID 12899525 DOI: 10.1007/978-3-642-55580-0_16  0.625
2003 Chen TC, Wang L, Whitlatch LW, Flanagan JN, Holick MF. Prostatic 25-hydroxyvitamin D-1alpha-hydroxylase and its implication in prostate cancer. Journal of Cellular Biochemistry. 88: 315-22. PMID 12520532 DOI: 10.1002/Jcb.10342  0.738
2002 Whitlatch LW, Young MV, Schwartz GG, Flanagan JN, Burnstein KL, Lokeshwar BL, Rich ES, Holick MF, Chen TC. 25-Hydroxyvitamin D-1alpha-hydroxylase activity is diminished in human prostate cancer cells and is enhanced by gene transfer. The Journal of Steroid Biochemistry and Molecular Biology. 81: 135-40. PMID 12137802 DOI: 10.1016/S0960-0760(02)00053-5  0.784
2001 Tangpricha V, Flanagan JN, Whitlatch LW, Tseng CC, Chen TC, Holt PR, Lipkin MS, Holick MF. 25-hydroxyvitamin D-1alpha-hydroxylase in normal and malignant colon tissue. Lancet (London, England). 357: 1673-4. PMID 11425375 DOI: 10.1016/S0140-6736(00)04831-5  0.651
2001 Flanagan JN, Whitlatch LW, Chen TC, Zhu XH, Holick MT, Kong XF, Holick MF. Enhancing 1 alpha-hydroxylase activity with the 25-hydroxyvitamin D-1 alpha-hydroxylase gene in cultured human keratinocytes and mouse skin. The Journal of Investigative Dermatology. 116: 910-4. PMID 11407980 DOI: 10.1046/J.1523-1747.2001.01360.X  0.664
1998 Schwartz GG, Whitlatch LW, Chen TC, Lokeshwar BL, Holick MF. Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25- hydroxyvitamin D3 Cancer Epidemiology Biomarkers and Prevention. 7: 391-395. PMID 9610788  0.647
Show low-probability matches.